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Abstract: Free radicals are common outcome of normal aerobic cellular metabolism. In-built antioxidant system of body 
plays its decisive role in prevention of any loss due to free radicals. However, imbalanced defense mechanism of antioxi-
dants, overproduction or incorporation of free radicals from environment to living system leads to serious penalty leading 
to neuro-degeneration. Neural cells suffer functional or sensory loss in neurodegenerative diseases. Apart from several 
other environmental or genetic factors, oxidative stress (OS) leading to free radical attack on neural cells contributes ca-
lamitous role to neuro-degeneration. Though, oxygen is imperative for life, imbalanced metabolism and excess reactive 
oxygen species (ROS) generation end into a range of disorders such as Alzheimer’s disease, Parkinson’s disease, aging 
and many other neural disorders. Toxicity of free radicals contributes to proteins and DNA injury, inflammation, tissue 
damage and subsequent cellular apoptosis. Antioxidants are now being looked upon as persuasive therapeutic against sol-
emn neuronal loss, as they have capability to combat by neutralizing free radicals. Diet is major source of antioxidants, as 
well as medicinal herbs are catching attention to be commercial source of antioxidants at present. Recognition of upstream 
and downstream antioxidant therapy to oxidative stress has been proved an effective tool in alteration of any neuronal 
damage as well as free radical scavenging. Antioxidants have a wide scope to sequester metal ions involved in neuronal 
plaque formation to prevent oxidative stress. In addition, antioxidant therapy is vital in scavenging free radicals and ROS 
preventing neuronal degeneration in post-oxidative stress scenario.  
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INTRODUCTION 
  Free radicals are molecules with unpaired electron in 
their outer orbit. Free radicals have very important role in 
origin of life and biological evolution, leaving beneficial 
effects on the organisms [57]. Oxygen radicals are involved 
in many biochemical activities of cells such as signal trans-
duction, gene transcription and regulation of soluble guany-
late cyclase activity. Nitric oxide (NO) is an important sig-
naling molecule that essentially regulates the relaxation and 
proliferation of vascular smooth muscle cells, leukocytes 
adhesion, platelets aggregation, angiogenesis, thrombosis, 
vascular tone and hemodynamics [95]. Humans are con-
stantly exposed to free radicals created by electromagnetic 
radiation from the manmade environment such as pollutants 
and cigarette smoke. Natural resources such as radon, cosmic 
radiation, as well as cellular metabolisms (respiratory burst, 
enzyme reactions) also add free radicals to the environment. 
The most common reported cellular free radicals are hy-
droxyl (OH·), superoxide (O2
–·) and nitric monoxide (NO·). 
Even some other molecules like hydrogen peroxide (H2O2)
and peroxynitrite (ONOO–) are not free radicals; they are 
reported to generate free radicals through various chemical 
reactions in many cases [30]. Cells exposed to environment  
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fortified with oxygen continuously generate oxygen free 
radicals (OFR). Antioxidants defense systems co-evolved 
along with aerobic metabolism to counteract oxidative dam-
age from OFR [92]. Human body produce oxygen free radi-
cals and other reactive oxygen species as by products 
through numerous physiological and biochemical processes. 
Oxygen related free radicals (superoxide and hydroxyl radi-
cals) and reactive species (hydrogen peroxide, nitric oxide, 
peroxynitrile and hypochlorous acid), are produced in the 
body, primarily as a result of aerobic metabolism [34, 66]. At 
the same time, antioxidants, such as glutathione, arginine, 
citrulline, taurine, creatine, selenium, zinc, vitamin E, vita-
min C, vitamin A and tea polyphenols help to regulate the 
ROS thus generated. Antioxidant is further supported with 
antioxidant enzymes, e.g. superoxide dismutase, catalase, 
glutathione reductase and glutathione peroxidase those exert 
synergistic actions in removing free radicals [66, 81, 93]. 
  Overproduction of free radicals can cause oxidative dam-
age to biomolecules, (lipids, proteins, DNA), eventually 
leading to many chronic diseases such as atherosclerosis, 
cancer, diabetics, rheumatoid arthritis, post-ischemic perfu-
sion injury, myocardial infarction, cardiovascular diseases, 
chronic inflammation, stroke and septic shock, aging and 
other degenerative diseases in humans [27, 93]. Excess NO 
is cytotoxic either by combining with tyrosine that is essen-
tial for catalytic function of enzyme ribonucleoside diphos-
phate reductase or by forming ONOO. Excess vascular O2
production could contribute to hypertension and vasospasm 
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  ROS are particularly active in the brain and neuronal 
tissue as the excitatory amino acids and neurotransmitters, 
whose metabolism is factory of ROS, which are unique to 
the brain and serve as sources of oxidative stress. ROS attack 
glial cells and neurons, which are post-mitotic cells and 
therefore, they are particularly sensitive to free radicals, 
leading to neuronal damage [30]. It has been reported that 
deleterious effects of ROS on human cells may end in oxida-
tive injury leading to programmed cell death i.e. apoptosis 
[71].  
  Antioxidants are classified as exogenous (natural or syn-
thetic) or endogenous compounds, both responsible for re-
moval of free radicals, scavenging ROS or their precursors, 
inhibiting formation of ROS and binding metal ions needed 
for catalysis of ROS generation. [30].  
  Natural antioxidant system is sorted in two major groups, 
enzymatic and non- enzymatic. Enzymatic antioxidants are 
comprised of limited number of proteins such as catalase, 
glutathione peroxidase as well as superoxide dismutase 
(SOD) along with some supporting enzymes. Non-enzymatic 
antioxidants include direct acting antioxidants, which are 
extremely important in defense against OS. Most of them 
include ascorbic and lipoic acid, polyphenols and caro-
tenoids, derived from dietary sources. The cell itself synthe-
sizes a minority of these molecules. Indirectly acting anti-
oxidants mostly include chelating agents and bind to redox 
metals to prevent free radical generation [30].  
Need of Antioxidants 
  It has been reported in epidemiological studies that many 
of antioxidant compounds posses anti inflammatory, antia-
therosclerotic, antitumor, antimutagenic, anticarcinogenic, 
antibacterial and antiviral activities to greater or lesser extent 
[59, 64, 70]. In many cases, increased oxidative stress is a 
widely associated in the development and progression of 
diabetes and its complications which are usually accompa-
nied by increased production of free radicals or failure of 
antioxidant defense [4, 5, 16, 18, 35, 58, 72, 91]. Though the 
intake of natural antioxidants has been reported to reduce 
risk of cancer, cardiovascular diseases, diabetes and other 
diseases associated with aging, there is considerable contro-
versy in this area [38, 47, 77, 87]. Leukocytes and other 
phagocyte destroy bacteria, parasites and virus-infected cells 
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with NO, O2, H2O2, and OCl, those are powerful oxidants 
and protect humans from infection. However, they cause 
oxidative damage and mutation to DNA and participate in 
the carcinogenic process if unchecked. In many cases, it is 
concluded that antioxidants modulate the pathophysiology of 
chronic inflammation up to some extent [54, 62, 73, 75, 76, 
86]. Moreover, experiments and studies infer that antioxi-
dants are needed to scavenge and prevent the formation of 
ROS and reactive nitrogen species (RNS); out of them, some 
are free radicals while some are not [3]. There is growing 
evidence that oxidative damage to sperm DNA is increased 
when there is ascorbate insufficiency in diet [8]. This 
strongly suggests the protective role of antioxidant in our 
daily diet. 
Sources of Antioxidants 
  Four endogenous sources appear to account for most of 
the oxidants produced by cells. (1) Normal aerobic respira-
tion in which mitochondria consume O2, reduces it by se-
quential steps to produce O2, H2O2, and -OH as byproduct. 
(2) Bacteria or virus infected cells get destroyed by phagocy-
tosis with an oxidative burst of nitric oxide (NO), O2
-, H2O2
and OCl. (3) Peroxisomes produce H2O2 as a by-product of 
fatty acid and other lipid molecular degradation, which is 
further degraded by catalase. Evidence suggests that, certain 
conditions favor escape of some of the peroxide from degra-
dation, consequently releasing it into other compartments of 
the cell and increasing oxidative stress leading to DNA dam-
age. (4) Animal Cytochrome P450 enzymes are one of the 
primary defense systems that provides protection against 
natural toxic chemicals from plants, the major source of die-
tary toxins. Even these enzymes are protective against acute 
toxic effects from foreign chemicals, yet they may generate 
some oxidative byproducts that damages DNA [8].  
  Various antioxidants are supplied to human body through 
diet, both vegetarian as well as non vegetarian. Vitamins C 
and E, -carotene and coenzyme Q are the most famous an-
tioxidants of diet, out of which, Vitamin E is present in vege-
table oils and found abundantly in wheat germ. It is fat solu-
ble vitamin, absorbed in the gut and carried in the plasma by 
lipoproteins. Out if 8 natural state isomeric forms of vitamin 
E, -tocopherol is the most common and potent isomeric 
form. Being lipid soluble, vitamin E can effectively prevent 
lipid peroxidation of plasma membrane [10, 11]. 
  Plants (fruits, vegetables, medicinal herbs) may contain a 
wide variety of free radical scavenging molecules such as 
phenolic compounds (Phenolic acids, flavonoids, quinons, 
coumarins, lignans, stilbenes, tannins etc.), nitrogen com-
pounds (alkaloids, amines, betalains etc.), vitamins, terpe-
noids (including carotenoids) and some other endogenous 
metabolites which are rich in antioxidant activity [15, 19, 83, 
96].  
NEURODEGENERATIVE DISEASES AND OXIDA-
TIVE STRESS 
  Neurodegenerative diseases comprise a condition in 
which nerve cells from brain and spinal cord are lost leading 
to either functional loss (ataxia) or sensory dysfunction (de-
mentia). Mitochondrial (Mt) dysfunctions and excitotoxicity 
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and finally apoptosis have been reported as pathological 
cause for aging and neurodegenerative diseases such as Park-
inson’s disease (PD), Alzheimer’s disease (AD), Multiple 
Sclerosis (MS) and amyolotrophic lateral sclerosis (ALS). 
Neurodegeneration have been speculated to be interplay of a 
number of factors including environmental and genetic pre-
disposition but redox metal abuse occupies central role as 
most of symptoms stems out from abnormal metal metabo-
lism [53]. Oxidative stress and free radical generation cata-
lyzed by redox metals have been shown to play pivotal role 
in regulating redox reactions in vivo contributing RNS and 
ROS, main culprits in neurodegeneration [42]. While consid-
ering role of oxidative stress in neurodegeneration, few im-
portant aspects need to be mentioned in brief are- 
1. Oxygen is important for cellular function and oxygen ex-
change is normal phenomena for oxidative phosphorylation 
in Mt, then how it becomes malicious for neuronal cells? 
2. Why neuronal cells particularly are most sensitive to oxi-
dative stress? 
3. What is the role of environmental and genetic factor in 
stimulating oxidative stress and subsequent neuronal cell 
death? 
4. How does unregulated metabolism of redox metal comes 
in picture in generating oxidative stress? 
Oxygen and Oxidative Stress 
  Oxygen is vital for all living cells whether neuronal or 
other kinds of cells taking part in tissue formation but on the 
other hand it is potentially dangerous in excess. Thus, it is 
kept under tight check of complex system that regulates and 
monitors the usage and uptake of this essential element. 
Oxygen takes part in glucose break down in Mt through oxi-
dative phosphorylation and generates energy currency of cell 
i.e. ATP [36]. Mt has its own molecular machinery (Mt 
DNA) for synthesis of enzyme and proteins required for oxi-
dative phosphorylation. Any mutation in Mt DNA leads to 
impaired ATP generation and perturbed oxidative phos-
phorylation cascade that may further lock the neuronal func-
tion [33]. Oxidative stress arises due to disturbed equilibrium 
between pro-oxidant/antioxidant homeostasis that further 
takes part in generation of ROS and free radicals those are 
potentially toxic for neuronal cells. The reason for neuronal 
cell hypersensitivity towards oxidative stress arises due to 
anatomic and metabolic factors. In the brain, various types of 
glial cells are present and these are involved in anatomic 
support and metabolic requirement. The endothelial cells 
surrounding these glial cells are less permeable for uptake of 
various molecules and protective cells viz. macrophages 
compared to other endothelial cells in the body. In addition, 
glial cells in brain require more oxygen and glucose con-
sumption to generate continuous ATP pool in vivo for nor-
mal functioning of brain as it is one of busiest organ to keep 
all other organs active and under control. That makes them 
more susceptible towards oxygen over load, thus free radical 
generation [49]. Under physiological condition, 1-2% of O2
consumed is converted to ROS but in aged brain this per-
centage goes up due to reduced surveillance of antioxidants 
and low regenerative capacity of aged brain [49]. 
ROS: Real Culprits for Neuronal Degeneration 
  ROS comprises hydrogen peroxide (H2O2), nitric oxide 
(NO), superoxide anions and the highly reactive hydroxyl 
and monoxide radicals (OH·, NO·). Damaged Mt and acti-
vated microglia acts as reservoir of ROS. Initially ROS gen-
eration was believed to be an outcome of imbalance between 
generation and elimination of ROS and RNS but recently 
many chemistries and molecular biology have been discov-
ered regulating ROS those play fundamental role in modulat-
ing key cellular functions [46]. For example, Haber Weiss 
and Fenton reaction initiate the free radical and ROS genera-
tion that activates mitogen activated protein (MAP) kinase 
cascade, excitotoxic calcium mobilization and finally apop-
totic cell death [40]. Free radicals have been reported for 
their great contribution to neuronal loss in cerebral ischemia, 
seizure disorders, schizophrenia, Parkinson's disease and 
Alzheimer's disease [14, 21, 67, 68, 79, 89, 90].  
Pathological Evidences of ROS Mediated Neuronal Dam-
age 
  Neuronal biochemical composition is mainly susceptible 
to ROS since it involves pool of unsaturated lipids those are 
labile to peroxidation and oxidative modification. Double 
bonds of unsaturated fatty acids are hot spots for attack by 
free radicals those initiate cascade or chain reaction to dam-
age neighboring unsaturated fatty acids [13]. Several re-
searchers considered brain to be abnormally sensitive to oxi-
dative damage and many studies demonstrative of the ease of 
peroxidation of brain membranes supported this notion [17, 
24, 94]. Brain contains high level of fatty acids which are 
more susceptible to peroxidation, that consumes an inordi-
nate fraction (20%) of total oxygen consumption for its rela-
tively small weight (2%). In addition, it is not particularly 
enriched in antioxidant defenses. Brain is lower in antioxi-
dant activity in comparison with other tissues, for example, 
about 10% of liver. Moreover, human brain has higher level 
of iron in certain regions and in general has high levels of 
ascorbate. As evident from above data, neural cells are con-
sidered to be more susceptible to oxidative damage as com-
pared to other body tissues [24].
Mechanism of ROS Generation 
  ROS generation is prerequisite of metabolic system in 
order to interact with organic molecules in vivo as interaction 
of organic molecules with oxygen is energetically unfavor-
able. In all forms of ROS generation, molecular oxygen 
needs to be activated and cellular system have evolved range 
of metallo-enzymes those facilitates ROS generation upon 
interaction of redox metals with O2 using various catalytic 
pathways. Since free radicals are toxic to cells, under normal 
circumstances, cells have efficient regulating system for O2
and metal ion interaction leading to free radicals and ROS 
generation [12]. 
Fe
3+ + ￿O2
  Fe
2+ + O2(Step I) 
Fe
2+ + H2O2  Fe
3+ + OH
 + ￿OH (Step II) * 
Combining step I&II 
￿O2
- + H2O2  ￿OH + HO
- + O2 * Known as Fenton reaction 
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  A part from direct ROS generation, there are different in 
vivo pathways those contribute substantively ROS generation 
by calcium activation with metallo-enzymes. Calcium is an 
important signaling molecule and it is required for many 
cellular responses and cell-cell communication. Thus, any 
disturbance in stimulus and regulation of calcium pathway 
may disrupt the cellular physiology [1]. 
Mechanism of ROS Mediated Cellular Apoptosis 
  As evident from terminology, ROS are extremely reac-
tive to different fundamental molecules in cellular pool and 
initiate cascade of reactions at same time that leads to neu-
ronal cell death. Oxidative over load in neuronal microenvi-
ronment causes oxidation of lipids, proteins and DNA and 
generates many byproducts such as peroxides, alcohols, al-
dehydes, ketones and cholesterol oxide. Most of them are 
toxic to blood lymphocyte and macrophages, paralyzing the 
in vivo defense system [23]. Cystine, lysine and Histidine 
residues in protein are hot spot for acrolein (oxidatively 
modified lipid) and NHE (Sodium Hydrogen Exchanger) for 
modification and they cross link these amino acid residues 
via Michael addition as given below [41].  
H
R' R
R"
H R"
R
R'
+
B:
Where B is the Base e.g. NaOH, KOH etc. 
  Acrolein hampers glutamate and sugar uptake where as 
NHE block neuronal ion transporters and activates c-Jun and 
MAP kinase pathways to invoke cellular apoptosis [45]. Pro-
tein modification leads to loss of function of enzymes regu-
lating oxidative balance in cellular system viz. glutamine 
synthase, superoxide dismutase. Most significant ill effect on 
neuronal health takes place by dysregulation of intracellular 
calcium signaling pathways initiated by ROS and in recent 
years heavy evidences suggest role of ROS in neuronal cell 
death [22]. Excitotoxic effects initiated by ROS induced in-
tracellular calcium influx leads to activation of glutamate 
receptors and apoptosis in Huntington’s, AD, PD and ALS. 
In addition, DNA mutations add further insult after ROS 
mediated modifications [55].
Metallobiology and Neurodegenerative Diseases (AD, PD, 
MS and ALS) 
  Most astounding effect of aging can be described as neu-
rodegeneration associated with disturbed metal metabolism. 
In aged brain, accumulation of redox metals (Copper, Iron 
and Zinc) have been found to substantively increased due to 
concentration of metals by blood brain barrier (BBB) at junc-
tion of neuronal environment and blood vessels. This makes 
aged brain more prone to initiate neurodegeneration in vicin-
ity of neuronal cells in brain [78]. 
  AD is characterized by Amyloid plaques deposition by 
chelating Amyloid- peptide (A) with transition metal ions 
(Cu
2+, Zn
2+and Fe
3+). Toxicity of A is attributed due to his-
tidine residues at position 6, 13 and 14 those are structural 
site for transition metal coordination. Binding of Cu
2+and 
Fe
3+produces toxic chemical reaction, altering oxidation state 
both the metals, producing H2O2 catalytically in presence of 
transition metals and finally gives toxic OH
˙ free radicals 
[63]. One interesting aspect about A plaques is that re-
searchers consider A plaques as toxic species responsible 
for AD but latest reports suggest A as a physiological anti-
oxidant and this property is modified due to aging. In future 
this property may be used as potent therapy for AD [20]. 
  PD is characterized by deposition of inclusion bodies 
(Lewy bodies) of -synuclein in substantia nigra that is 
ubiquitously expressed in brain and mutation in this principle 
protein is reported in familial forms of AD [28]. Dopamine 
has a good reputation as neurotransmitter but at the same 
time it is very good metal chelator and electron donor that set 
in vivo conditions for redox metal chemistry to generate 
toxic free radicals. It has high tendency to coordinate with 
Cu
2+ and Fe
3+ and reducing metals to initiate Fenton’s chem-
istry to generate H2O2 [29]. Evidences indicate that muta-
tions in -synuclein protein has a role in modulating the do-
pamine activity but in negative way that initiates neuronal 
cytoplasmic accumulation and interaction of dopamine with 
iron, engendering ROS production [51]. In addition, muta-
tions in -synuclein support various intracellular pathways 
those dysregulate dopamine-metal interactions and ROS 
generations. An example is loss of neuromelanin cell from 
substantia nigra in PD patient. Neuromelanin is dark brown 
pigment with unknown function but strong evidence suggest 
that it accumulates redox metals in aged brain and supposed 
to be product of dopamine redox chemistry [84]. 
 InMSandexperimentalallergicencephalomyelitis  (EAE), 
an animal models of MS, have been characterized as auto-
immune neuronal disorder that causes demylination of cen-
tral nervous system (CNS). Unregulated iron metabolism and 
ROS generation have been named as major player in patho-
genesis of disease. High lipid content generated by myelin 
and oligodendrocytes invite massive accumulation of iron 
and other metals since redox metals acts as catalytic center 
for this lipid factory. Iron plaque deposited over myelin 
sheath invokes an inflammatory response that triggers re-
cruitment of inflammatory cell such as tissue macrophage 
and T cells entering into CNS to cause substantive damage 
and demyelination to CNS [80]. 
  In ALS, like MS, lower motor neurons from spinal cord 
and cerebral cortex are lost due to deposition of a misfolded 
protein in neuronal tissue in relation with toxic gain of func-
tion by mutated sulfur oxide dismutase (SOD) enzyme asso-
ciated with Cu/Zn redox metallobiology [52]. Gain in toxic 
function in mutated SOD is due to loss of active sites for Cu 
binding that leads to conversion of SOD itself in pro-oxidant 
protein that participates in ROS generation [82]. 
  Apart from aforementioned neuronal disorders, In Frie-
dreich’s ataxia, loss of mitochondrial protein frataxin is 
caused by abnormal iron accumulation and ROS generation. 
In addition, iron overload causes mitochondrial respiratory 
chain breakdown and oxidative stress leading to cardiomy-
opathy and neurodenegeration [7]. 
Genetic Evidences in Neurodegenerations and Oxidative 
Stress 
  Oxidative stress related neurodegeneration is not only 
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suggests that persons associated with certain types of genetic 
mutations are more susceptible to gain neurological patho-
logical compare to normal to those with normal genetic pro-
file. Person with hemochromatosis (HFE) associated muta-
tions may be on higher side of developing iron over load 
related oxidative stress and neuropathology with ingestion of 
daily iron supplement [31,37]. Metal metabolism is com-
bined interplay between genes related with synthesis of met-
alloenzymes and dietary metal supplement. Any imbalance 
in this interaction favors dysregulated cellular metallobiol-
ogy that subsequently leads to neurodegenerations. Clini-
cians suggests it is made to be mandatory to counsel the pa-
tients with associated mutations and increased risks of neu-
rodegeneration.  
Antioxidant Therapeutic Option to Upstream of OS: En-
zymes and Antioxidants Dedicated to Regulate Protein-
Transition Metal Interaction and Reduce Free Radical 
Generation 
  Antioxidants are exogenous or endogenous molecules 
those act against any form of oxidative stress and its associ-
ated ill effects on cellular system. They neutralize ROS and 
other kinds of free radicals produced as consequence of OS 
and have attracted the attention of clinicians due to therapeu-
tic potential. Thanks to our daily diet that contains millions 
of natural antioxidants in form of flavonoids and phenolic 
compounds, lipoic acid (thioctic acid), ubiquinone and ide-
benone, -carotene and vitamin C as metabolic supplements 
and keeps all our vital organs free from OS [49].  
  As stated above the prime focus of antioxidant therapy 
should be to interrupt and modulate the neuronal protein 
interaction with culprit redox metals instead of therapeutic 
approaches surrounding downstream effect of ROS. Thus, 
antioxidant therapy preventing corruption and breakdown of 
metalloenzyme and innate antioxidant defense system sup-
porting proportional metal homeostasis will gain clinical 
appraisal. So for, hallmark therapeutic strategies clinically 
target the relevant transition metals, those take part in neu-
rodegeneration. In certain cases, anti-inflammatory drugs are 
given as supplement at onset of neurological disorder to pac-
ify immune system as in certain circumstances; immune sys-
tem is significantly provoked due to oxidative stress. Anti-
oxidant therapy involving enzymes and anti-inflammatory 
drugs constitute upstream therapy in ROS generation and 
prevent downstream pathologies in advance in certain neu-
rodegeneration. Oxyradicals have a very short life (1 s) and 
usually are inactivated or scavenged by antioxidants before 
they can inflict damage to lipids, proteins or nucleic acids. In 
this regard, pathology due to ROS can be checked by at least 
two mechanisms  
Inactivation of oxyradicals by dietary antioxidants like vita-
min C, vitamin E, -carotene. 
Replacement of esterified membrane phospholipids with 
polyunsaturated fatty acids (PUFAs) by dietary supplementa-
tion with essential fatty acids [10].  
Dietary Natural Antioxidants as Upstream Preventive 
Measure 
  There are clinical evidences that neurodegenerations can 
be ameliorated upon dietary intake or supplementary intake 
of natural antioxidants. Dietary intake contains variety of 
antioxidants vitamin supplements those play a vital role in 
neuroprotection in variety of neurological disorders [65]. 
  These natural antioxidants prevent oxidation of proteins, 
lipid peroxidations and prevent generation of ROS, thus act 
as upstream therapeutic barrier to OS. 
  One of important futuristic upstream therapeutic aspect 
that can regulate oxidative stress to protect neuronal cells 
from death is vaccination against potential toxic protein 
formed in different types of neuronal disorders. A promising 
example is Amyloid- vaccination in AD that prevents 
plaque formation and subsequent neuron inflammation [43]. 
This could be a therapeutic strategy for other neurological 
disorders lead by OS, such as in MS.  
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Downstream Antioxidant Therapy in ROS Mediated 
Neuronal Disorder: Preventing Neuronal Inflammation 
and Free Radical Scavenging 
  Point of ROS generation and past events embark a num-
ber of side reaction those directly or indirectly initiate neu-
ronal interaction. Thus, there must be therapeutic coverage 
for such post oxidative stress events. A number of natural 
and synthetic products have been advised to work in neuro-
protection to combat the ill effects oxidative stress. Ginkgo 
biloba (EGb 761), famous Chinese herb has been known for 
its excellent antioxidant properties that restrict -amyloid 
toxicity after plaque formation [88]. In mild AD patients, it 
is shown that EGb 761 improves cognitive activities and 
neuronal function though in severe AD, neuroprotective role 
of EGb 761 seems to be reduced. Inflammatory reactions are 
most common features of all forms of neuronal disorders. 
Non Steroidal Anti-inflammatory Drugs (NSAIDS) are most 
praised downstream therapeutics, ameliorating inflammatory 
infiltration of macrophages. They act as antioxidants to re-
duce inflammatory cascade induced by oxidative stress [25]. 
CPI-1189, a nitrone related compound is supposed to down-
regulate the pro-inflammatory cytokine cascade of genes in 
primary glial cells. In this regard, nitron and related com-
pounds are under phase III clinical trial for potential com-
mercial applications [26]. In addition, in vivo proteins and 
growth factors such as brain derived neurotrophic factors, 
responsible for enhancing memory and cognitive function in 
OS, can be induced in response to promote growth and sur-
vival of deteriorating neurons [56]. 
  Another chemical moiety that resembles vitamin E in its 
chemical structure is female sex hormone estrogen (estra-
diol) that contains a phenolic free radical scavenging site and 
acts as anti oxidant. Interestingly, it posses capability to pre-
vent an upstream neurodegeneration and downstream the 
oxidative overload. For example, 17 -Estradiol prevents neu-
ronal cell death either inhibiting H2O2 formation or prevent-
ing A toxicity, the 2 events taking place before and after of 
oxidative stress respectively. Antioxidant properties of these 
phenolic compounds are due to interaction of their functional 
group with the redox metals, not on account of their cellular 
oestrogen receptors [32]. Table 1 gives details of prominent 
antioxidant with their class, mechanism of action and referral 
of neurodegenerative disorder. 
Modulation of Calcium Mediated Excitotoxic Effects as 
Therapeutic Options 
  Disruption of homeostatic metal metabolic pathways by 
ROS leads to increased intracellular calcium levels that 
cause neuronal cell death due to dysregulated microtubules 
assembly and axonal transport. In vitro studies had shown 
the capabilities of natural oxidants such as Taxol in prevent-
ing neuronal cell death by preventing microtubule disaggre-
gation [9]. This gives vital downstream therapeutic target to 
prevent calcium mediated neurotoxicity in clinical AD, PD 
and ALS. 
Challenges in Designing Pre and Post Oxidative Stress 
Antioxidants Therapeutics 
  The major challenge in designing synthetic antioxidant to 
protect brain cognitive function due to neuronal death is 
movement across blood brain barrier (BBB). Chemical open-
ing due to osmotic differential pressure at BBB tight junction 
or pathological openings due to trauma or pathogenic causes 
Table 1.  Details of Prominent Antioxidant with their Class, Mechanism of Action and Referral of Neurodegenerative Disorder
Class Chemical  Composition  Mechanism  of  Action 
Neuronal Disorder 
Studied 
Reference 
Direct Antioxi-
dant 
Aryl amines and indoles-carotene, lycopene 
Polyenes- carotene, lycopene, retinol Sele-
nium containing compounds ebselen. Poly-
phenols- Flavonoids, stilbenes, and hydroqui-
none Monophenols: tocopherols(vitamin E), 
17-estradiol (estrogen), 5-hydroxytryptamine 
(serotonin) 
direct chemical (nonenzy-
matic)scavenging of ROS generated 
free radicals and get some of them are 
recycled with endogenous oxidoreduc-
tases or via intracellular reducing shut-
tles 
neuroprotection in 
Alzheimer’s disease 
6, 37 
Indirect antioxi-
dant 
Amino oxidase inhibitors, calcium antago-
nists, dopamine receptor agonists, glutamate 
receptor antagonists, ion chelators, nitric 
oxide synthase inhibitors 
Prevent excitotoxicity, ROS and free 
radical generation targeting inhibitors 
and receptors dysregulating metal ho-
meostasis 
Parkinson’s disease and 
dementia 
37, 84 
Metabolic anti-
oxidant 
N-acetyl-cysteine, glutathione, 2-oxo-
thiazolidine-4-carboxylate, and other thiol-
delivering compounds 
N-butyl- -phenylnitrone. Carnitine, 
creatine, lipoic acid (thioctic acid), 
ubiquinone and idebenone 
nullify cellular damage caused by free 
radicals by reducing secondary meta-
bolic burden over cellular organelle(Mt, 
vesicles and cell membrane 
Neuroprotection in 
general 
44, 2 
Metal containing 
antioxidant 
Manganese-containing mimetics of cata-
lase/superoxide dismutase 
Enzymatic mimicking prevents protein-
metal interaction 
Mt protection in AD 
and PD 
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are the means to molecular motion across BBB. Coenzyme 
Q10 (ubiquinone), GSH and oxidized form of vitamin C 
have shown substantive ability to cross BBB in human and 
rodent models [30]. Thus, designing artificial antioxidant 
drugs for neuroprotection must accompany aforementioned 
structure analogue in order to cross BBB and circulate in 
brain neuronal circuitry. 
Concluding Remarks and Future Perspective  
  It is clear from current neurobiology research that un-
regulated metal metabolism plays catastrophic role in cata-
lysing  in vivo chemical reactions those lead to oxidative 
stress and neuronal cell death as final cause. Though metals 
are crucial as cofactors to carry out numerous in vivo cata-
lytic enzymatic reactions in cellular metabolism and cell 
signalling. Any mutations in Mt DNA or metal overload in 
aged brain leads to oxidative stress and free radical mediated 
pathological changes in neurons. Neuronal proteins and 
structural components get modified due to OS in different 
neurological disorders leading to neuro-inflammation and 
loss of cognitive function in AD, PD, MS and ALS. Since in 
this review, OS have been defined as principle pathological 
cause of neurodegeneration, antioxidants are proposed as 
therapeutic options to combat the free radical generation and 
maintenance. This review covers the sources of antioxidants 
and free radicals and general mechanism involve in antioxi-
dant mediated free radical scavenging. Major emphasis have 
been given on the role of oxidative stress and free radical 
chemistry with respect to major neurodegenerative disorders 
viz. AD, PD, MS and ALS. We report major antioxidant 
therapeutic target those are capable in neuroprotection before 
OS (upstream), majority preventing free radical generation, 
modulating metal-neuronal protein interaction and promoting 
normal metal homoeostasis. In additions, we have given an 
account of antioxidant in post OS (downstream) taking care 
of neuronal inflammation and free radical scavenging with 
challenges in designing therapeutic antioxidants.  
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